In Vitro Activity of Novel Rifamycins against Gram-positive Clinical Isolates

スポンサーリンク

概要

• 論文の詳細を見る
• 2007-09-25

著者

• Murphy Christopher

  米国

• Murphy Christopher

  Activbiotics Inc.

• ROTHSTEIN David

  ActivBiotics, Inc.

• Rothstein David

  Activbiotics Inc.

• KARGINOVA Elena

  Eurofins Medinet, Inc.

• SAHM Dan

  Eurofins Medinet, Inc.

• Sahm Dan

  Eurofins Medinet Inc.

• Karginova Elena

  Eurofins Medinet Inc.

• Rothstein David

  米国

• MURPHY Christopher

  ActivBiotics, Inc.

関連論文

• Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse Model of H. pylori Colonization
• In Vitro Activity of Novel Rifamycins against Gram-positive Clinical Isolates
• Bactericidal Efficacy of ABI-0043, a Novel Rifamycin, in a Murine Pneumococcal Pneumonia Model
• Rifalazil Retains Activity Against Rifampin-resistant Mutants of Chlamydia pneumoniae
• Enhanced Activity of Rifalazil in Combination with Levofloxacin, Linezolid, or Mupirocin against Staphylococcus aureus In Vitro
• In Vitro Time-kill Activities of Rifalazil, Alone and in Combination with Vancomycin, against Logarithmic and Stationary Cultures of Staphylococcus aureus

スポンサーリンク